Why is Link Pharma Chem falling/rising?

As of 11-Sep, Link Pharma Chem Ltd is experiencing a decline in its stock price, currently at 35.00, reflecting a decrease of 0.7 or 1.96%. The stock has underperformed its sector today by 1.82%, and it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Over the past week, the stock has dropped by 1.41%, and it has seen a significant decline of 14.63% year-to-date. The company's financial health is concerning, with a -183.49% CAGR growth in operating profits over the last five years and a negative return on equity of 5.21%. Additionally, the net sales and profit after tax for the last nine months have both decreased by 21.03%, indicating weak performance.
In the broader market context, while Link Pharma Chem has underperformed significantly, the Sensex has shown a positive return of 1.03% over the past week and 4.36% year-to-date. This stark contrast highlights the company's struggles relative to the overall market. The stock's liquidity appears adequate, with a notable increase in delivery volume, but the underlying fundamentals remain weak, making it a risky investment. The company's inability to generate positive operating profits and service its debt effectively further exacerbates the situation, leading to a bearish outlook for the stock.